BWS Financial reiterated coverage on Hawkins with a new price target
$HWKN
Specialty Chemicals
Consumer Discretionary
BWS Financial reiterated coverage of Hawkins with a rating of Buy and set a new price target of $44.00 from $33.50 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/1/2025 | $125.00 | Market Outperform | CJS Securities |
| 10/16/2024 | Buy → Neutral | BWS Financial | |
| 8/7/2023 | $62.00 | Neutral → Buy | BWS Financial |
| 2/3/2022 | $44.00 → $52.00 | Buy | BWS Financial |
ROSEVILLE, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of the assets of Amerochem Corporation. Amerochem distributes water treatment chemicals and equipment for its customers primarily throughout North Carolina. "The Amerochem acquisition represents our second acquisition in North Carolina and our 50th Water Treatment location across the U.S. We have known Amerochem for decades and are glad to have them as a part of Hawkins," said Hawkins Chief Executive Officer Patrick H. Hawkins. "Amerochem has built an incredible business over the past 30 plus years and has great relatio
ROSEVILLE, Minn., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced results for the nine months ended December 29, 2024, its third quarter of fiscal 2025. Third Quarter Fiscal Year 2025 Highlights: Record third quarter results for revenue, gross profit, operating income, and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("adjusted EBITDA"), a non-GAAP measure.Overall revenue growth of 8%, once again driven by the Water Treatment segment growth of 22% over the same period of the prior year.Gross profit growth of 15% over the same period of the prior year, with double-digit percentage growth for both the Water Treatment and Health a
ROSEVILLE, Minn., Jan. 29, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on January 29, 2025, declared a quarterly cash dividend of $0.18 per share, payable February 28, 2025, to shareholders of record at the close of business on February 14, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, distributes, blends, and manufactures products for its Industrial, Water Treatment, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, the Company has 61 facilities in 28 states
SC 13G/A - HAWKINS INC (0000046250) (Subject)
SC 13G/A - HAWKINS INC (0000046250) (Subject)
SC 13G/A - HAWKINS INC (0000046250) (Subject)
8-K - HAWKINS INC (0000046250) (Filer)
10-Q - HAWKINS INC (0000046250) (Filer)
8-K - HAWKINS INC (0000046250) (Filer)
4 - HAWKINS INC (0000046250) (Issuer)
4 - HAWKINS INC (0000046250) (Issuer)
4 - HAWKINS INC (0000046250) (Issuer)
ROSEVILLE, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of the assets of Amerochem Corporation. Amerochem distributes water treatment chemicals and equipment for its customers primarily throughout North Carolina. "The Amerochem acquisition represents our second acquisition in North Carolina and our 50th Water Treatment location across the U.S. We have known Amerochem for decades and are glad to have them as a part of Hawkins," said Hawkins Chief Executive Officer Patrick H. Hawkins. "Amerochem has built an incredible business over the past 30 plus years and has great relatio
ROSEVILLE, Minn., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (NASDAQ:HWKN) today announced results for the nine months ended December 29, 2024, its third quarter of fiscal 2025. Third Quarter Fiscal Year 2025 Highlights: Record third quarter results for revenue, gross profit, operating income, and adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("adjusted EBITDA"), a non-GAAP measure.Overall revenue growth of 8%, once again driven by the Water Treatment segment growth of 22% over the same period of the prior year.Gross profit growth of 15% over the same period of the prior year, with double-digit percentage growth for both the Water Treatment and Health a
ROSEVILLE, Minn., Jan. 29, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Hawkins, Inc. (NASDAQ:HWKN), at its meeting on January 29, 2025, declared a quarterly cash dividend of $0.18 per share, payable February 28, 2025, to shareholders of record at the close of business on February 14, 2025. Hawkins has consistently paid out a dividend since 1985. About Hawkins, Inc. Hawkins, Inc. was founded in 1938 and is a leading water treatment and specialty ingredients company that formulates, distributes, blends, and manufactures products for its Industrial, Water Treatment, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, the Company has 61 facilities in 28 states
CJS Securities initiated coverage of Hawkins with a rating of Market Outperform and set a new price target of $125.00
BWS Financial downgraded Hawkins from Buy to Neutral
BWS Financial upgraded Hawkins from Neutral to Buy and set a new price target of $62.00
4 - HAWKINS INC (0000046250) (Issuer)
4 - HAWKINS INC (0000046250) (Issuer)
4 - HAWKINS INC (0000046250) (Issuer)
BALATON, Minn., Aug. 16, 2023 /PRNewswire/ -- The trū® Shrimp Companies, Inc. ("trū Shrimp") announced today that trū Shrimp has appointed Hawkins, Inc. ("Hawkins") (NASDAQ:HWKN) as the exclusive distributor of its trū® Chitosan products into the United States' pharmaceutical and medical device industries. trū Chitosan is derived from the exoskeletons of trū Shrimp's production of consumer shrimp. Chitosan is a molecule refined from the shell of shrimp and is used for numerous pharmaceutical and medical applications. trū Shrimp is the only United States producer of chitosan that meets the strict medical specifications of the United States Pharmacopoeia – National Formulary (USP-NF) monograph
Minneapolis, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced that John S. McKeon has notified us of his retirement from our Board of Directors and its committees effective as of December 31, 2020. Mr. McKeon has been a member of the Board since 1984 and has served as Chair of the Board since 2005. “We will miss Jack on the Board and appreciate his many years of dedicated service to Hawkins,” said Patrick H. Hawkins, Chief Executive Officer and President. “Over the 36 years that Jack has served on the Board, we have seen Hawkins grow tremendously in both size and scope. With his support and guidance, we have built a solid company that is poised for cont